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Abstract
Background and Purpose—Blood pressure (BP) is a predictor of concurrent and subsequently
measured white matter hyperintensity (WMH), but longitudinal studies of WMH change and data in
black participants are lacking. We hypothesized that WMH progression would be 1) strongly related
to BP in blacks and whites, and 2) predicted more strongly by earlier (midlife) or cumulative BP
measurements than by measures at older ages.
Methods—Participants were 983 individuals (49% African-American) from the Atherosclerosis
Risk in Communities (ARIC) Study, who underwent cerebral MRIs in 1993–5 and 2004–6.
Associations between BP (measured at each of five visits, in addition to a time-averaged cumulative
BP) and progression of WMH were analyzed and compared.
Results—Cumulative SBP was the strongest BP predictor of WMH progression in adjusted models.
Higher cumulative SBP by 20 mm Hg was associated with greater progression of WMH, and was
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similar in blacks (2.5 cc; p<0.0001) and whites (2.6 cc; p<0.0001). Higher cumulative SBP (per 20
mm Hg) was also associated with being in the top quintile of WMH progression (adjusted OR 2.0;
95% CI 1.6–2.6). Earlier SBP measurements were stronger predictors of WMH progression than
later SBP, in blacks only.
Conclusions—In this population-based cohort, cumulative SBP was a stronger predictor of WMH
progression than SBP from individual visits, in both blacks and whites. Earlier BPs were stronger
predictors than BPs measured at later timepoints, in blacks only.
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Cerebrovascular injury from systemic disease takes the form not only of discrete strokes, but
also of white matter injury. In past epidemiologic studies associations between vascular risk
factors and resultant white matter disease1, 2 or cognitive impairment3–5 have been strongest
when the risk factor was measured in midlife.
In general, blacks have more hypertension and more white matter disease than whites.6
Whether the excess of white matter disease in blacks is entirely due to differences in
hypertension prevalence, severity or control, or whether hypertension differentially affects
blacks, as compared to whites, is not fully explored. In addition, whether measurement of risk
in midlife is as important in blacks, compared to whites, has not been evaluated. Finally, few
prior studies have explored associations between vascular risk factors, such as BP, and
progression of white matter disease. Progression of white matter disease has been identified
as a more important predictor of cognitive decline than baseline white matter disease volume,
7 and therefore warrants further study.
In the Atherosclerosis Risk in Communities (ARIC) cohort, we investigated associations
between BP measurements over different time points over nearly 20 years, and progression of
white matter hyperintensity (WMH) volume. We hypothesized that BP would be strongly
associated with WMH progression and that this relationship would be: (1) at least as strong in
black as in white participants; and (2) stronger when BP was measured earlier in life or
summarized using a cumulative average compared to BP measured at later time points.
MATERIALS AND METHODS
Study Population
ARIC is a prospective study of middle-aged African-American and white men and women
designed to investigate the natural history of atherosclerosis and its sequelae. At baseline
(1987–89), 15,792 participants were sampled from four U.S communities: Forsyth County,
NC; Jackson MS, suburbs of Minneapolis MN, and Washington County, MD. African-
Americans were sampled exclusively in Jackson and over-sampled in Forsyth to facilitate race-
specific analyses. The other two sites were predominantly white. Race and ethnicity were self-
identified.
Study design and procedures have been published.8 After the baseline (visit 1), participants
returned in 1990–1993 (visit 2), 1993–1995 (visit 3), 1996–1999 (visit 4), and, for a subset,
2004–2006 (Brain MRI visit, visit 5). At all visits concurrent medical, social, and medication
history was collected, and BPs were measured.
Participants aged 55 and older at the Jackson and Forsyth County sites were invited for a brain
MRI at visit 3 (1,949 individuals completed an MRI).9 All subjects without MRI
contraindications who completed the visit 3 MRI were invited for a 2nd MRI scan between
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2004–2006. These participants were more likely to be African-American than the remainder
of the living ARIC sample, with comparable numbers of females.
Brain MRI
Visit 3—Visit 3 brain MRI’s were performed on 1.5T scanners, and 5-mm thick contiguous
axial images were obtained9, 10 and interpreted at the ARIC MRI Reading Center. Proton-
density-weighted images were viewed to grade the relative severity of WMH using a 0 to 9
scale developed for the Cardiovascular Health Study (CHS)11 (referred to in this manuscript
as “White matter grade”). Subcortical and periventricular WMH were visually evaluated
together. The reproducibility of visual scoring of WMH in CHS was good, with inter- and
intra-reader agreement within 1 grade of 92% and 94.5%, and relaxed kappas of 0.81 and 0.93,
respectively.11 White matter grade was evaluated on all visit 3 brain MRI’s.
Visit 5—In 2004–2006, as part of the ARIC Brain MRI ancillary study (visit 5), 1,134
participants underwent a second 1.5T brain MRI. These scans were rated using both the
qualitative white matter grade, and a semiautomated volumetric analysis. Brain and
leukoaraiosis volumes were determined from axial fluid-attenuated inversion recovery
(FLAIR) images. An automated algorithm was used to segment each of the FLAIR images into
voxels assigned to one of three categories based on signal intensity — normal brain, CSF, or
leukoaraiosis. The leukoaraiosis maps were manually edited to exclude infarcts and other
lesions. The mean absolute error and test-retest coefficient of variation for this method are
6.6% and 1.4%, respectively, for leukoaraiosis volume. Total intracranial volume was
manually measured from T1-weighted sagittal images. Volumetric measurements of WMH
were standardized to an intracranial volume of 1500 cc.
Two individuals with severe WMH at visit 3 were excluded (white matter grade 7), because
these individuals would be unlikely to show progression. Nine subjects were excluded because
of prevalent stroke at visit 3. The final sample included 983 individuals with interpretable MRI
scans from both visits.
Calculation of WMH change
Fully quantitative WMH volumes were not possible from all visit 3 scans. Therefore, WMH
volume at visit 3 was estimated using a prediction equation (R2=0.80) relating volume from
visual grades (Figure 1). The prediction equation was created using actual data from visit 5
(visual grades and quantitative volumes). Visit 3 visual grades were then entered into the
equation to calculate estimated visit 3 volumes. Change in WMH volume was calculated by
subtracting estimated WMH volume at visit 3 from WMH volume at visit 5. One value with
an apparent decrease of > 20 cc was excluded, as this was likely due to measurement error.
Blood Pressure
Sitting brachial BP was measured using standardized protocols by trained technicians using a
random zero sphygmomanometer, with 5 minutes’ rest between measurements. At all visits,
blood pressure was measured 3 times, and our analyses use the average of the last 2 values for
that visit.
Antihypertensive medications were recorded at each visit. A cumulative, time-averaged value
was calculated, yielding a value between 0 and 1 for each individual’s proportion of time they
had spent over the duration of the study on the medication.
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Stata version 8.2 for Macintosh was used.12 White matter disease progression was analyzed
continuously and as quintiles of WMH volume change. Cross-sectional measures of SBP at
each of the ARIC visits were considered as well as cumulative SBP measures. The cumulative
values, determined as the area-under-the-curve of exam-specific values divided by time
between first and last exam, can be interpreted as the estimated mean daily SBP over the entire
period. Other covariates included age, sex, race, body mass index from visit 3 (BMI), visit 3
smoking status, diabetes (fasting glucose≥ 126 mg/dL at visit 3), education (categorized <=8,
9–11, 12–13, 14–16, 17–20, or >=21 years), and prevalent coronary heart disease (visit 3).
Linear regression was used to determine the association between SBP and WMH volume
change (with larger values indicating a larger increase in WMH volume from visit 3 to 5), and
logistic regression was used to estimate its effect on the risk of being in the highest quintile
(vs. the lower 4 quintiles) of WMH volume change. Models were analyzed for the entire sample
and separately by race.
A separate analysis was performed to compare the effect of “early” (visits 1 and 2) versus
“late” (visits 4 and 5) SBP on WMH volume change, using averages of visit 1 and 2 SBP
(“early”) and of visit 4 and 5 SBP (“late”). Both of these averaged SBPs were entered into the
same race, sex, and age-adjusted model, to determine the association of early versus late SBP
with WMH volume change independent of SBP at the other time point.
We also analyzed the role of antihypertensive medications in the association between SBP and
white matter disease. Based on methods reported previously,13 a constant of 10 mm Hg was
added to the SBP value from a given visit for any individual on antihypertensive treatment at
the time of that visit. For cumulative SBP modeling, if the individual had been on an
antihypertensive medication at least 50% of the time, the same constant was added to the
cumulative SBP value. Additional analyses were conducted adjusting for cumulative
antihypertensive use (between 0 and 1) as a covariate. Secondary analyses were also performed
adjusting for baseline (visit 3) WMH. Finally, we performed a secondary analysis using change
in WMH visual grade from visit 3 to visit 5 as the dependent variable. These models were
estimated using ordinal logistic regression. Change in WMH visual grade was calculated by
subtracting grade at visit 3 from grade at visit 5.
RESULTS
Patient characteristics
As seen in Table 1, approximately half of the participants were black, and SBP was generally
higher at later than at earlier visits. Distribution of white matter grade among individuals who
underwent MRI at both visits (3 and 5) is displayed in Figure 2. Fewer than 4% of whites,
compared with 10% of blacks, progressed by ≥2 grades (p<0.0001). WMH volume
(standardized to 1500 cc total intracranial volume) at visit 5 averaged 13 cc (median 9.1 cc),
SD was 11 cc, maximum value 90 cc. The average WMH change (from visit 3 to 5) was 5.2
cc (median 2.7 cc, SD 8.6).
Analysis of WMH volume change as continuous variable
Analyzed as a continuous variable, SBP was strongly associated with WMH volume change
(Table 2). Cumulative mean SBP was a stronger predictor than SBP measured at the different
examinations. Earlier SBP values had stronger associations with change in WMH than SBP
values measured later, but in stratified analysis, this was seen only for blacks. In adjusted
models, each 20 mm Hg higher cumulative mean SBP was associated with a 2.4 cc greater
increase in WMH volume between visits 3 and 5 with a similar association in blacks and whites
(2.5 cc and 2.6 cc respectively, Table 2).
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A race X SBP interaction term was significant for visits 1 and 2, indicating that the association
between WMH volume and SBP measured at these early visits was stronger in blacks. The
race × SBP interaction was not significant in the models for visits 3, 4, or 5, or cumulative
SBP.
Analysis of ”significant progression”
Figure 3 shows the adjusted odds ratio (per 20 mm Hg (approximately 1 SD) increase in SBP)
of being in the highest quintile of change in WMH volume in the range of 1.3 to 2.3 for SBP
measured at the different visits (or using a cumulative value).
Analysis of effect of timing of SBP measurement in prediction of WMH volume change
Inclusion of both early SBP (an average of SBP from the first two visits) and late SBP (average
of values from visits 4 and 5) in the same age- and sex-adjusted model permitted assessment
of the importance of the timing of BP in predicting WMH progression. In a model including
all participants, beta coefficients were similar (0.91 and 1.51 cc of progression per 20 mm Hg)
for early versus late SBP values (respectively). Findings were similar in white participants.
However, in black participants, the coefficient associated with an equivalent difference (20
mm Hg) in SBP from early visits was 2.17 cc (95% CI 0.96–3.38), after adjustment for later
SBP, compared to only 0.68 cc additional WMH progression associated with a difference of
20 mm Hg in later visits (after adjustment for earlier SBP).
Secondary analyses
When use of antihypertensive medications is accounted for by adding a 10 mm Hg constant,
as described in the methods section, the association with SBP was partially attenuated but
remained significant. Complete results when cumulative use of antihypertensive medication
is included as a covariate, in the prediction of worst amount of WMH change (top quintile),
are included in the Supplementary table. Cumulative SBP remains the most important
predictor.
When the continuous analyses were repeated including adjustment for WMH grade at visit 3,
results remained statistically significant, but point estimates were moderately decreased.
When the primary analyses were repeated but using change in WMH grade (without using the
estimated volumes), similar results were found, with the strongest effect from the cumulative
SBP value. The adjusted OR for advancing one category in WMH visual grade, per 20 mm Hg
of SBP, was 1.27 when SBP was measured from visit 1 (95% CI 1.10–1.48), 1.24 (95% CI
1.07–1.44) from visit 2, 1.14 (1.00–1.30) from visit 3, 1.30 (95% CI 1.13–1.48) from visit 4,
1.18 (95% CI 1.04–1.35) from visit 5, and 1.46 for cumulative SBP (95% CI 1.22–1.75).
DISCUSSION
In this large cohort with serial BP measurements and two MRI studies per subject, cumulative
mean SBP was a much stronger predictor of white matter disease progression than SBPs from
individual time points. In blacks, earlier (midlife) measurements of SBP had slightly stronger
associations with WMH change than did later measurements. More blacks than whites had
substantial progression of WMH, although an equivalent increase in cumulative mean SBP
was associated with similar increases in WMH volume change in blacks and whites.
Substantially more blacks had a known diagnosis of hypertension (41.6%) at the start of the
ARIC study than did whites (16.6%). Perhaps the ethnic differences in progression may reflect
longer duration of hypertension in blacks, even earlier than measured in this study.
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Although others have hypothesized that WMH may result from degenerative or demyelinating
injury,14 our results support a significant vascular component to the progression of WMH.
Our findings are also consistent with previous studies suggesting the importance of
measurement of vascular risk factors in midlife in predicting subsequent cognitive impairment
and white matter disease; 1–5, 15 Other studies have supported a relatively weak cross-
sectional association between measurement of BP and white matter hyperintensity. In the
Cardiovascular Health Study, in participants over 65, higher SBP was associated with higher
white matter grade (graded categorically).16 Our focus was on progression of WMH; we did
find evidence for an association between SBP measured at the time of the first MRI and WMH
progression, but found that in blacks (who have not been as well represented in other
epidemiologic studies) it was not as strong as associations with SBP measured prior to the first
MRI. We cannot explain the relative lack of influence of earlier SBP values in whites in this
study. Whites had less baseline WMH, so had lower volumes of WMH in general. The effect
of SBP on WMH progression in whites was quite variable from visit to visit. This variability
remained even after adjustment for antihypertensive medication use. Blood pressure variability
in general warrants further study, as wide fluctuations in blood pressure may be problematic
for the integrity of the white matter.
To our knowledge, a cumulative variable, taking into account SBP levels over approximately
15 years, has not been explored previously to describe relationships with white matter disease.
Its effect size portends the potential utility of this measure in future studies on the long-term
effects of hypertension. The association between WMH progression and a 20 mm Hg higher
cumulative SBP was equivalent to the increase in progression associated with a 7–8 year
difference in baseline age.
In the Rotterdam study, higher SBP and DBP both predicted the progression of periventricular
WM disease, but this was using a categorical scale, their effect sizes tended to be smaller, for
comparable differences in WMH progression, and their results were not significant
consistently.17,18 This may be because the Rotterdam study recruited primarily white
participants with access to excellent health care, who, as our results suggest, may have weaker
associations between early BP measurements and white matter disease. We also believe that
the additional information provided by volumetric measurement of white matter disease helps
to better define the extent of disease progression.
Mechanisms underlying WMH are important to explore given the known relationships between
WMH and subsequent dementia or cognitive impairment.19,20 Progression may be particularly
important; in one recent study, individuals who became cognitively impaired had an average
increase of WMH of 2.4 cc/year, compared to those who were cognitively intact (mean WMH
increase 0.8 cc/year).
A limitation of this study is the lack of direct volumetric imaging at the 3rd visit. However, the
validity of our approach for estimating visit 3 WMH volumes based on the relationship between
categorical and volumetric ratings at visit 5 is supported by the excellent fit by the equation
we used for making those estimates. Another limitation is the lack of information about
ambulatory BP. Given that cumulative SBP was a strong predictor of white matter disease,
detailed ambulatory BP measurements might provide even stronger prediction but are cost
prohibitive and impractical over any lengthy time frame. Associations were still present, though
attenuated, when antihypertensive use was included in models, suggesting that some injury
from hypertension might be eliminated by the use of antihypertensives. However, the degree
to which an individual’s SBP was lowered by medications could not be well examined in this
study, using our methods, since some individuals might have better control on antihypertensive
medications, others might require 3 or 4 medications, and still others might be on
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antihypertensive medications, but for reasons other than blood pressure control (for instance,
beta-blockers for rate control in atrial fibrillation).
Persons who completed both cerebral MRIs may represent a biased sample of the population.
Individuals with more advanced leukoaraiosis or with dementia might be underrepresented.
This potential bias might be conservative-- leading us to underestimate the strength of the
associations between blood pressure and white matter disease progression.
The strengths of this study include the large sample size with excellent follow-up, standardized
measurement of blood pressure and other vascular risk factors, and the availability of serial
MRI scans in a largely asymptomatic population. We believe that our use of the volumetrics
provides an advantage over the use of categorical ratings, as has been typically used in other
studies. We have shown the importance of BP in subclinical vascular disease. Further studies
may focus on clinical sequelae. Because white matter disease has been associated with
cognitive dysfunction, reduction in white matter disease progression may be a means by which
long-term antihypertensive treatment might prevent cognitive impairment and dementia. In
our study, the relationship between SBP and white matter disease was linear, suggesting that
changes in SBP are critical across a wide range of values. The relative health of the sample,
however, limits our ability to make conclusions about individuals with very high or very low
BP values, as there were very few individuals at these extremes.
SUMMARY
Cumulative SBP provides valuable information in estimating risk of progression of white
matter disease, beyond that of BPs taken at individual time points. In blacks, earlier BPs may
be more important than later life blood pressures in predicting white matter disease progression.
These findings further emphasize the importance of persistently elevated BP in the
development of subclinical cerebral vascular disease.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Scatterplot of semiautomated white matter volume for each qualitative white matter grade.11
Both measurements are made from the same follow-up Brain MRI (visit 5). The line shows a
quadratic fit of the data.
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Distribution of white matter grade categories at visits 3 and 5, by race. Diagonal line
demonstrates no change in grade. Larger circles indicate more individuals.
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Adjusted odds ratios (OR) of top quintile of change in white matter hyperintensity volume, per
20 mm Hg higher SBP at varying time points and shown by race. Cumulative time-averaged
SBP and SBP measurements from each visit are displayed.
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Table 1
Characteristics of ARIC participants who completed 2 interpretable MRI scans (N=983)
Variable
% Black (N (%)) 485 (49.3%)
% Female (N (%)) 605 (61.6%)
Age at visit 5 (mean (SD)) 72 (4)
Visit 1 SBP (mm Hg) (mean (SD)) 121 (17)
Visit 2 SBP (mm Hg) (mean (SD)) 120 (18)
Visit 3 SBP (mm Hg) (mean (SD))* 126 (19)
Visit 4 SBP (mm Hg) (mean (SD)) 129 (19)
Visit 5 SBP (mm Hg) (mean (SD))* 133 (19)
Cumulative mean SBP (mm Hg) (mean (SD)) 127 (14)
% Hypertension** (visit 1) (N (%)) 358 (37%)
% History of myocardial infarction (visit 1) (N (%)) 10 (1%)
% Diabetes Mellitus*** (visit 1) (N (%)) 78 (8%)
% Current smoking (visit 1) (N (%)) 189 (19%)
% Prevalent Coronary Heart Disease (visit 1) 13 (1%)
Body Mass Index (visit 1) (kg/m2) (mean (SD)) 27 (4)
*
Brain MRI was also done at these visits.
**
Defined as SBP≥140/90 mm Hg or hypertension medication use in preceding two weeks.
***
Defined as fasting glucose≥126 mg/dL
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